Platform
One platform. Multiple programmes.
Each programme targets one health problem that gets worse with age. Each runs through the same in vivo path and leaves through our brands, a licence or co-development.
Ongoing programmes.
Natural-compound formulations, validated in vivo. Food supplement route.
Status shows the furthest stage reached, out of six stages: Planned, Research, Formulated, Regulatory, Manufacturing, Selling.
| Programme | Product | Status | Route | Open for |
|---|---|---|---|---|
| Sleep qualityHeat and stress | SiestaK | Selling · stage 6 of 6 |
Own brand | On market |
| Sexual function · women | BLUFEM | Selling · stage 6 of 6 |
Own brand | On market |
| Sexual function · men | BluGent | Formulated · stage 3 of 6 |
Distribution | US distributors |
| Cold tolerance & performanceOutdoor work · winter sport | AlpineFlame | Research · stage 2 of 6 |
Licence | Licensing |
| Stress & anxiety | MenusStress | Research · stage 2 of 6 |
Own brand | In-house |
| Hedonic appetite | MenusAppetite | Planned · stage 1 of 6 |
Own brand | In-house |
| Male fertility | Fertilia Seminal | Planned · stage 1 of 6 |
Co-development | Co-development |
| Menopause symptoms | MenusPausia | Planned · stage 1 of 6 |
Co-development | Co-development |
Have another health problem in mind?
Ask us about a new programme.
Open now
Looking for partners and funding.
Licensing
AlpineFlame
Cold tolerance and performance. In research. For sports nutrition, outdoor work and winter sports.
Distribution
BluGent
Formulated. We are looking for distributors in the US, where the full formulation is accepted.
Co-development
Fertilia Seminal and MenusPausia
Male fertility and menopause. Planned. Open to co-development partners.
Investors
Fund a programme
Support a programme in research or planned, or open a new one with us.
How we work
From health problem to in vivo validated formulation.
01
Identify the model
We pick health challenges that are not classified as diseases. Then we build in vivo models that reproduce them at the whole-body level, with phenotypic, physiologically relevant readouts.
02
Compound discovery
Using scientific literature, our own datasets and AI tools, we rank candidate compounds by their potential to act on the target biology.
03
In vivo validation and formulation
Candidates are tested in our models at our CRO. The ones that work are combined into multi-compound formulations.
Our in vivo studies are carried out by VivoArchitect Sàrl, a contract research organisation (CRO) in Lausanne.
Visit vivoarchitect.com